Product Pathways - Apoptosis
Caspase-5 Antibody #4429
|4429S||100 µl (10 western blots)||---||In Stock||---|
|4429||carrier free and custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
Caspase-5 Antibody detects endogenous levels of total caspase-5 protein. This antibody detects the p20 subunit of active caspase-5.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu130 within the p20 subunit of human caspase-5 protein. Antibodies were purified by protein A and peptide affinity chromatography.
Western blot analysis of extracts from THP-1, HT-1080 and Ramos cells using Caspase-5 Antibody.
Western blot analysis of extracts from recombinant, active caspase-1, -4, and -5 using Caspase-5 Antibody.
Western blot analysis of extracts from THP-1 cells, differentiated with TPA (12-O-Tetradecanoylphorbol-13-Acetate) #4174 (80 nM, overnight) followed by LPS (1 μg/ml) for the indicated times, using Caspase-5 Antibody.
Caspase-5 (Ich-3/ICErelIII/TY) is a member of the caspase family of cysteine proteases that play a key role in the execution of apoptosis and activation of inflammatory cytokines (1-3). Caspase-5 is widely expressed, with highest expression observed in placenta and lung (1). Interferon-γ and LPS regulate expression of caspase-5 (2,4). Members of the caspase-1 subfamily of caspases, which includes caspase-4, -5, and murine caspase-11 and -12, can induce apoptosis when over-expressed and mediate the proteolytic activation of inflammatory cytokines (5). Processing of IL-1β occurs through the activation of an inflammasome complex consisting of caspase-1, caspase-5, Pycard and NALP1 (6). Transcription factor Max, a component of the Myc/Mad/Max network, is cleaved by caspase-5 during Fas-induced apoptosis (7). Several alternative spliced variants of caspase-5 have been identified (8). Frameshift mutations of caspase-5 have been observed in leukemia, lymphoma (9), and colorectal cancers (10).
- Munday, N.A. et al. (1995) J Biol Chem 270, 15870-6.
- Wang, S. et al. (1996) J Biol Chem 271, 20580-7.
- Faucheu, C. et al. (1996) Eur J Biochem 236, 207-13.
- Lin, X.Y. et al. (2000) J Biol Chem 275, 39920-6.
- Martinon, F. and Tschopp, J. (2007) Cell Death Differ 14, 10-22.
- Martinon, F. et al. (2002) Mol Cell 10, 417-26.
- Krippner-Heidenreich, A. et al. (2001) Biochem J 358, 705-15.
- Eckhart, L. et al. (2006) Biochem Biophys Res Commun 348, 682-8.
- Takeuchi, S. et al. (2003) Leuk Res 27, 359-61.
- Trojan, J. et al. (2004) Int J Colorectal Dis 19, 538-44.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.